Innoviva, Inc. (INVA)
NASDAQ: INVA · Real-Time Price · USD
21.05
+0.39 (1.89%)
At close: Oct 26, 2026, 4:00 PM EDT
22.00
+0.95 (4.51%)
After-hours: Oct 26, 2026, 7:55 PM EDT
Innoviva Employees
Innoviva had 159 employees as of December 31, 2025. The number of employees increased by 32 or 25.20% compared to the previous year. That makes Innoviva the 28,407th largest employer in the world and 3,596th in the United States.
Employees
159
Change (1Y)
32
Growth (1Y)
25.20%
Revenue / Employee
$2,767,283
Profits / Employee
$2,246,767
Market Cap
1.52B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Ultragenyx Pharmaceutical | 1,371 |
| Ascentage Pharma Group International | 828 |
| Intellia Therapeutics | 377 |
| Ocular Therapeutix | 325 |
| Structure Therapeutics | 281 |
| uniQure | 221 |
| Absci | 140 |
| AnaptysBio | 104 |
INVA News
- 7 days ago - Innoviva Specialty Therapeutics to Present Data Across Infectious Disease Portfolio at IDWeek 2026 - Business Wire
- 21 days ago - Russian plague outbreak could boost these under-the-radar pharma stocks - Invezz
- 4 weeks ago - Innoviva assumed with an Outperform at Oppenheimer - TheFly
- 6 weeks ago - Innoviva Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 6 weeks ago - Innoviva Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 7 weeks ago - Innoviva to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - Innoviva management to meet virtually with Cantor Fitzgerald - TheFly
- 2 months ago - Innoviva Specialty Therapeutics' Antimicrobial Therapies, XACDURO®, ZEVTERA® and NUZOLVENCE® Designated Finalists for the 2026 Prix Galien USA Best Pharmaceutical Product Award - Business Wire